A drug with extensive first-pass metabolism is administered orally. How will its bioavailability compare to the same drug administered intravenously?
Approximately the same
Significantly higher
Unpredictable due to individual variability
Significantly lower
✓
Correct Answer
Significantly lower
Significantly lower: Oral drugs with extensive first-pass metabolism are metabolized by the liver before reaching systemic circulation, reducing bioavailability compared to intravenous administration which bypasses the liver initially. Significantly higher: This is incorrect; intravenous administration provides 100% bioavailability, and oral administration with first-pass metabolism will always be less. Approximately the same: This is incorrect; the first-pass effect directly reduces the amount of drug reaching systemic circulation after oral administration. Unpredictable due to individual variability: While some variability exists, the general trend of reduced bioavailability due to first-pass metabolism is predictable and significant.
Question 2
Which of the following is the primary mechanism by which Angiotensin-Converting Enzyme (ACE) inhibitors lower blood pressure?
Enhancing the reabsorption of sodium and water in the renal tubules
Preventing the conversion of angiotensin I to angiotensin II
✓
Increasing the release of renin from the kidneys
Directly blocking angiotensin II receptors
Correct Answer
Preventing the conversion of angiotensin I to angiotensin II
Preventing the conversion of angiotensin I to angiotensin II: ACE inhibitors block the enzyme responsible for converting inactive angiotensin I into the potent vasoconstrictor angiotensin II, leading to vasodilation and reduced blood pressure. Directly blocking angiotensin II receptors: This is the mechanism of Angiotensin Receptor Blockers (ARBs), not ACE inhibitors. Increasing the release of renin from the kidneys: ACE inhibitors actually lead to an increase in renin release due to a loss of negative feedback from angiotensin II, but this is a compensatory effect, not the primary blood pressure lowering mechanism. Enhancing the reabsorption of sodium and water in the renal tubules: This action would increase blood volume and blood pressure, which is contrary to the effect of ACE inhibitors.
Question 3
A patient receiving morphine for post-surgical pain develops constipation. Which mechanism primarily explains this common adverse effect?
Decreased gastrointestinal motility
✓
Increased fluid secretion into the bowel
Direct irritation of the colonic mucosa
Enhanced parasympathetic activity in the gut
Correct Answer
Decreased gastrointestinal motility
Increased fluid secretion into the bowel: Increased fluid secretion would lead to diarrhea, not constipation. Decreased gastrointestinal motility: Opioids bind to mu-opioid receptors in the GI tract, reducing propulsive contractions and delaying transit time, leading to constipation. Direct irritation of the colonic mucosa: While some drugs can irritate the mucosa, this is not the primary mechanism of opioid-induced constipation. Enhanced parasympathetic activity in the gut: Opioids generally inhibit parasympathetic activity in the gut, which would contribute to decreased motility, not enhanced activity.
Question 4
A patient with a history of asthma is prescribed a beta-blocker for hypertension. Which of the following adverse effects is a significant concern for this patient?
Bronchoconstriction
✓
Hyperglycemia
Peripheral vasodilation
Tachycardia
Correct Answer
Bronchoconstriction
Tachycardia: Beta-blockers typically cause bradycardia (slowing of heart rate), not tachycardia. Bronchoconstriction: Non-selective beta-blockers can block beta-2 receptors in the bronchial smooth muscle, leading to bronchoconstriction, which is dangerous for patients with asthma. Hyperglycemia: While beta-blockers can mask symptoms of hypoglycemia and slightly impair glucose metabolism, they do not directly cause hyperglycemia. Peripheral vasodilation: Beta-blockers generally cause peripheral vasoconstriction or have no direct vasodilatory effect, not vasodilation.
Question 5
A physician orders a continuous intravenous infusion of dopamine at 5 mcg/kg/min for a 70 kg patient. The pharmacy supplies dopamine as 200 mg in 250 mL D5W. What is the infusion rate in mL/hr?
17.5 mL/hr
26.25 mL/hr
✓
42 mL/hr
10.5 mL/hr
Correct Answer
26.25 mL/hr
17.5 mL/hr: This calculation may result from errors in unit conversion or concentration. 26.25 mL/hr: The total dose needed is 5 mcg/kg/min * 70 kg = 350 mcg/min, which is 0.35 mg/min or 21 mg/hr. The concentration is 200 mg/250 mL = 0.8 mg/mL. So, 21 mg/hr / 0.8 mg/mL = 26.25 mL/hr. 42 mL/hr: This calculation likely involves a significant error in dose or concentration. 10.5 mL/hr: This calculation may result from incorrect multiplication or division during the conversion steps.
Question 6
A drug has a half-life of 6 hours. If a patient starts a continuous intravenous infusion of this drug, approximately how long will it take to reach steady-state plasma concentrations?
12 hours
6 hours
24-30 hours
✓
48 hours
Correct Answer
24-30 hours
6 hours: This represents one half-life, where 50% of steady state is reached, not steady state itself. 24-30 hours: It typically takes approximately 4 to 5 half-lives for a drug to reach steady-state plasma concentrations during continuous infusion. 4 half-lives (24 hours) achieves 93.75% of steady state, and 5 half-lives (30 hours) achieves 96.875%. 12 hours: This represents two half-lives, where 75% of steady state is reached. 48 hours: While steady state would be achieved by this time, it is significantly longer than the typical 4-5 half-lives required.
Question 7
Furosemide, a loop diuretic, exerts its primary effect by inhibiting which of the following?
Na+/Cl- cotransporter in the distal convoluted tubule
Carbonic anhydrase in the proximal tubule
Na+/K+/2Cl- cotransporter in the thick ascending limb of the loop of Henle
✓
Aldosterone receptors in the collecting duct
Correct Answer
Na+/K+/2Cl- cotransporter in the thick ascending limb of the loop of Henle
Na+/K+/2Cl- cotransporter in the thick ascending limb of the loop of Henle: Furosemide inhibits this cotransporter, preventing the reabsorption of sodium, potassium, and chloride, leading to significant diuresis. Carbonic anhydrase in the proximal tubule: This is the mechanism of carbonic anhydrase inhibitors like acetazolamide. Na+/Cl- cotransporter in the distal convoluted tubule: This is the mechanism of thiazide diuretics. Aldosterone receptors in the collecting duct: This is the mechanism of potassium-sparing diuretics like spironolactone and eplerenone.
Question 8
A patient taking ibuprofen daily for chronic arthritis pain reports new onset of epigastric pain and dark, tarry stools. Which of the following is the most likely cause?
Gastric ulceration
✓
Acute liver failure
Hypersensitivity reaction
Nephrotoxicity
Correct Answer
Gastric ulceration
Acute liver failure: While NSAIDs can rarely cause liver injury, epigastric pain and dark, tarry stools (melena) are not primary symptoms of acute liver failure. Nephrotoxicity: NSAIDs can cause kidney injury, but this would not directly explain epigastric pain and melena. Gastric ulceration: NSAIDs inhibit prostaglandin synthesis, which protects the gastric mucosa. This can lead to ulceration and bleeding, manifested as epigastric pain and melena. Hypersensitivity reaction: Hypersensitivity reactions typically involve rash, urticaria, or anaphylaxis, not these specific gastrointestinal symptoms.
Question 9
What is the primary mechanism of action of statin medications in lowering cholesterol levels?
Blocking intestinal cholesterol absorption
Increasing bile acid excretion
Activating lipoprotein lipase
Inhibiting HMG-CoA reductase
✓
Correct Answer
Inhibiting HMG-CoA reductase
Inhibiting HMG-CoA reductase: Statins competitively inhibit HMG-CoA reductase, a key enzyme in the cholesterol synthesis pathway in the liver, thereby reducing endogenous cholesterol production. Increasing bile acid excretion: This is the mechanism of bile acid sequestrants. Activating lipoprotein lipase: This is a mechanism associated with fibrates, which primarily reduce triglycerides. Blocking intestinal cholesterol absorption: This is the mechanism of ezetimibe.
Question 10
A partial agonist is characterized by which of the following properties?
It binds to a receptor and produces a maximal effect
It binds to a receptor at a site distinct from the agonist binding site
It binds to a receptor but produces a submaximal effect even at full receptor occupancy
✓
It binds to a receptor but produces no effect, preventing agonist binding
Correct Answer
It binds to a receptor but produces a submaximal effect even at full receptor occupancy
It binds to a receptor but produces a submaximal effect even at full receptor occupancy: A partial agonist has affinity for a receptor but less intrinsic activity than a full agonist, meaning it cannot elicit a maximal response even when all receptors are occupied. It binds to a receptor and produces a maximal effect: This describes a full agonist. It binds to a receptor but produces no effect, preventing agonist binding: This describes a competitive antagonist. It binds to a receptor at a site distinct from the agonist binding site: This describes an allosteric modulator, which can be an allosteric agonist or antagonist, but not necessarily a partial agonist.
Question 11
A patient is prescribed amoxicillin 250 mg orally three times a day. The pharmacy supplies amoxicillin oral suspension 125 mg/5 mL. How many milliliters should the patient take per dose?
2.5 mL
10 mL
✓
20 mL
5 mL
Correct Answer
10 mL
5 mL: This would be the correct dose if the prescribed amount was 125 mg, not 250 mg. 10 mL: The desired dose is 250 mg. The available concentration is 125 mg per 5 mL, which simplifies to 25 mg/mL. Therefore, 250 mg / 25 mg/mL = 10 mL. 2.5 mL: This calculation is incorrect and would result in an underdose. 20 mL: This calculation is incorrect and would result in an overdose.
Question 12
Which of the following conditions is a significant contraindication for the use of metformin due to an increased risk of lactic acidosis?
Controlled hypertension
Severe renal impairment
✓
Mild liver dysfunction
Hypothyroidism
Correct Answer
Severe renal impairment
Hypothyroidism: Hypothyroidism is not a contraindication for metformin. Controlled hypertension: Controlled hypertension is not a contraindication for metformin. Severe renal impairment: Metformin is primarily eliminated by the kidneys. In severe renal impairment, metformin accumulates, increasing the risk of lactic acidosis, making it a significant contraindication. Mild liver dysfunction: While caution is advised in liver dysfunction, severe renal impairment is a more direct and stronger contraindication for metformin due to the risk of lactic acidosis.
Question 13
Warfarin exerts its anticoagulant effect by interfering with which of the following?
Vitamin K-dependent clotting factor synthesis
✓
Potentiating the action of antithrombin III
Blocking platelet aggregation
Directly inhibiting thrombin activity
Correct Answer
Vitamin K-dependent clotting factor synthesis
Directly inhibiting thrombin activity: This is the mechanism of direct thrombin inhibitors like dabigatran. Vitamin K-dependent clotting factor synthesis: Warfarin inhibits vitamin K epoxide reductase, an enzyme necessary for the activation of vitamin K-dependent clotting factors (II, VII, IX, X), thereby reducing their synthesis. Potentiating the action of antithrombin III: This is the mechanism of action for heparin and low molecular weight heparins. Blocking platelet aggregation: This is the mechanism of antiplatelet drugs like aspirin and clopidogrel.
Question 14
A drug is found to have 100% bioavailability. This means that:
The entire administered dose reaches the systemic circulation
✓
The drug has a very long half-life
The drug is completely absorbed from the gastrointestinal tract
The drug is eliminated solely by renal excretion
Correct Answer
The entire administered dose reaches the systemic circulation
The drug is completely absorbed from the gastrointestinal tract: While complete absorption is necessary for high bioavailability, it does not account for first-pass metabolism, which can still reduce the amount reaching systemic circulation. The entire administered dose reaches the systemic circulation: Bioavailability is the fraction of an administered dose of unchanged drug that reaches the systemic circulation, so 100% bioavailability means the entire dose makes it. The drug is eliminated solely by renal excretion: The route of elimination is independent of the definition of bioavailability. The drug has a very long half-life: Half-life is a measure of the rate of elimination, which is distinct from the extent of absorption and first-pass metabolism (bioavailability).
Question 15
A patient switches from an ACE inhibitor to an Angiotensin Receptor Blocker (ARB) due to a persistent dry cough. This change is effective because ARBs:
Directly stimulate beta-2 adrenergic receptors
Do not inhibit the breakdown of bradykinin
✓
Have a shorter half-life, leading to less accumulation
Reduce aldosterone secretion more effectively than ACE inhibitors
Correct Answer
Do not inhibit the breakdown of bradykinin
Directly stimulate beta-2 adrenergic receptors: This is an unrelated mechanism; ARBs do not stimulate beta-2 receptors. Do not inhibit the breakdown of bradykinin: ACE inhibitors block the enzyme ACE, which also metabolizes bradykinin. The accumulation of bradykinin is thought to cause the dry cough. ARBs block the angiotensin II receptor directly and do not affect bradykinin metabolism. Reduce aldosterone secretion more effectively than ACE inhibitors: While ARBs do reduce aldosterone, this is not the primary reason for the absence of cough. Have a shorter half-life, leading to less accumulation: Half-life varies among individual drugs within both classes, and a shorter half-life does not explain the absence of cough.
Question 16
An order states to infuse 1000 mL of 0.9% NaCl over 8 hours. The IV tubing delivers 15 drops/mL. What is the drip rate in drops per minute?
125 gtts/min
19 gtts/min
63 gtts/min
31 gtts/min
✓
Correct Answer
31 gtts/min
125 gtts/min: This calculation may result from incorrectly using mL/hr as the rate before applying the drop factor. 63 gtts/min: This calculation likely involves an error in the drop factor or time conversion. 31 gtts/min: The total volume is 1000 mL over 8 hours (480 minutes). So, (1000 mL / 480 min) * 15 drops/mL = 31.25 drops/min, which rounds to 31 gtts/min. 19 gtts/min: This calculation likely involves an error in the drop factor or time conversion.
Blocking the reuptake of serotonin into presynaptic neurons
✓
Inhibiting monoamine oxidase enzymes
Increasing the synthesis of norepinephrine
Blocking dopamine receptors in the limbic system
Correct Answer
Blocking the reuptake of serotonin into presynaptic neurons
Blocking the reuptake of serotonin into presynaptic neurons: SSRIs selectively block the serotonin transporter, increasing the concentration of serotonin in the synaptic cleft, thereby enhancing serotonergic neurotransmission. Inhibiting monoamine oxidase enzymes: This is the mechanism of Monoamine Oxidase Inhibitors (MAOIs). Blocking dopamine receptors in the limbic system: This is the mechanism of action for many antipsychotic medications, not SSRIs. Increasing the synthesis of norepinephrine: While some antidepressants affect norepinephrine, SSRIs primarily target serotonin reuptake, not its synthesis.
Question 18
Which of the following patient characteristics would most likely lead to a reduced rate of drug elimination for renally excreted medications?
Higher plasma protein binding
Decreased glomerular filtration rate
✓
Increased hepatic enzyme activity
Increased gastrointestinal motility
Correct Answer
Decreased glomerular filtration rate
Increased hepatic enzyme activity: This affects liver metabolism, not directly the renal elimination of renally excreted medications. Higher plasma protein binding: While high protein binding can reduce the fraction of free drug available for filtration, a significantly decreased glomerular filtration rate (GFR) is a more direct and impactful cause of reduced renal elimination for drugs primarily excreted by the kidneys. Decreased glomerular filtration rate: The GFR is a primary measure of kidney function and directly reflects the rate at which drugs are filtered from the blood into the urine. A decrease in GFR significantly reduces renal drug elimination. Increased gastrointestinal motility: This primarily affects drug absorption, not elimination.
Question 19
Before administering a dose of digoxin, a nurse should assess the patient for which of the following, as it could indicate potential toxicity or a contraindication?
Constipation
Hypertension
Bradycardia (heart rate below 60 bpm)
✓
Hyperkalemia
Correct Answer
Bradycardia (heart rate below 60 bpm)
Hypertension: Digoxin primarily affects cardiac contractility and heart rate, not typically blood pressure, and hypertension is not a specific indicator of digoxin toxicity. Hyperkalemia: Hypokalemia (low potassium) increases the risk of digoxin toxicity, while hyperkalemia (high potassium) can actually decrease it. Bradycardia (heart rate below 60 bpm): Digoxin slows the heart rate. Pre-existing bradycardia or a significant drop in heart rate (typically below 60 bpm) may indicate digoxin toxicity or a need to hold the dose to prevent further cardiac depression. Constipation: While constipation can be a side effect of some medications, it is not a specific or common indicator of digoxin toxicity or a reason to hold the dose.
Question 20
Penicillin antibiotics achieve their bactericidal effect by targeting which bacterial component?
Bacterial DNA replication
Bacterial folic acid synthesis
Peptidoglycan cell wall synthesis
✓
Bacterial ribosomal protein synthesis
Correct Answer
Peptidoglycan cell wall synthesis
Bacterial ribosomal protein synthesis: This is the target for antibiotics like macrolides, tetracyclines, and aminoglycosides. Bacterial DNA replication: This is the target for antibiotics like fluoroquinolones. Peptidoglycan cell wall synthesis: Penicillins, along with other beta-lactam antibiotics, inhibit the transpeptidases (penicillin-binding proteins) involved in the cross-linking of peptidoglycan, which is essential for bacterial cell wall integrity, leading to cell lysis. Bacterial folic acid synthesis: This is the target for sulfonamides and trimethoprim.
Question 21
A pediatric patient weighing 15 kg requires a medication at a dose of 10 mg/kg. The medication is available as 50 mg/mL. How many milliliters should be administered?
1.5 mL
7.5 mL
5 mL
3 mL
✓
Correct Answer
3 mL
1.5 mL: This calculation is incorrect and would result in an underdose. 3 mL: The total dose needed is 10 mg/kg * 15 kg = 150 mg. With a concentration of 50 mg/mL, the volume to administer is 150 mg / 50 mg/mL = 3 mL. 5 mL: This calculation is incorrect and would result in an overdose. 7.5 mL: This calculation is incorrect and would result in a significant overdose.
Question 22
An elderly patient receiving an anticholinergic medication for overactive bladder reports experiencing dry mouth, blurred vision, and difficulty urinating. These symptoms are primarily due to the drug's effect on which receptor system?
Alpha-adrenergic receptors
Dopamine receptors
Nicotinic acetylcholine receptors
Muscarinic acetylcholine receptors
✓
Correct Answer
Muscarinic acetylcholine receptors
Nicotinic acetylcholine receptors: These receptors are primarily involved in skeletal muscle contraction and ganglionic transmission, and their blockade would not directly cause this specific constellation of symptoms. Muscarinic acetylcholine receptors: Anticholinergic drugs block muscarinic acetylcholine receptors. Blocking these receptors leads to characteristic side effects such as dry mouth (decreased salivary secretion), blurred vision (cycloplegia and mydriasis), and urinary retention (decreased detrusor muscle contraction), which are common with drugs for overactive bladder. Alpha-adrenergic receptors: These receptors primarily mediate vasoconstriction, pupil dilation, and bladder neck contraction. While alpha-blockade can affect urination, it does not explain dry mouth and blurred vision. Dopamine receptors: These receptors are involved in mood, motor control, and other functions, and their blockade would not directly cause these specific anticholinergic symptoms.